Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways

Publication profile

Expertise in Rheumatology: Dr. Shumnalieva has extensive experience in rheumatology, working at the largest university clinic for rheumatic diseases in Bulgaria. Her PhD thesis focuses on epigenetic modifications and their relation to rheumatic diseases, demonstrating in-depth research in disease mechanisms.

Clinical Integration: Her research not only addresses theoretical aspects but also their application in clinical practice. Her work includes utilizing advanced techniques such as MSUS, capillaroscopy, and mini-invasive arthroscopy, showcasing her hands-on expertise in treating and monitoring patients.

Translational Medicine Experience: Her fellowship at GBRC (Glasgow) and AMC (Amsterdam) provided her valuable experience in translational medicine, bridging the gap between laboratory research and clinical application.

COVID-19 Research Contributions: Dr. Shumnalieva has co-authored significant research papers in top-tier journals, contributing to global studies on COVID-19 and its impact on autoimmune diseases, which underscores her relevance in current medical challenges.

Multidisciplinary Collaborations: Her publications involve multidisciplinary, international collaborations on critical topics such as coronary artery diseases in vasculitides, multimorbidity in inflammatory myopathies, and lung involvement in systemic sclerosis.

Public Health and Patient Care: With a Master’s in Public Health, Dr. Shumnalieva also explores the correlation between risk factors and rheumatic diseases, adding a valuable population health perspective to her research.

Publication Record: With a solid portfolio of peer-reviewed articles in highly respected journals like Rheumatology International and International Journal of Rheumatic Diseases, Dr. Shumnalieva’s research addresses critical issues like the effect of multimorbidity on quality of life and disease flares post-COVID-19 infection.